Seroprevalence of SARS-CoV-2 in Guilan Province, Iran, April 2020

We determined the seroprevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in an affected area in northern Iran in April 2020. Antibodies to SARS-CoV-2 were detected in 528 persons by using rapid tests. Adjusted prevalence of SARS-CoV-2 seropositivity was 22.2% (95% CI 16.4%–28...

Descripción completa

Detalles Bibliográficos
Autores principales: Shakiba, Maryam, Nazemipour, Maryam, Salari, Arsalan, Mehrabian, Fardin, Nazari, Seyed Saeed H., Rezvani, Seyed Mahmoud, Ghasempour, Zahra, Heidarzadeh, Abtin, Mansournia, Mohammad Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2021
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7853569/
https://www.ncbi.nlm.nih.gov/pubmed/33349310
http://dx.doi.org/10.3201/eid2702.201960
_version_ 1783645989644533760
author Shakiba, Maryam
Nazemipour, Maryam
Salari, Arsalan
Mehrabian, Fardin
Nazari, Seyed Saeed H.
Rezvani, Seyed Mahmoud
Ghasempour, Zahra
Heidarzadeh, Abtin
Mansournia, Mohammad Ali
author_facet Shakiba, Maryam
Nazemipour, Maryam
Salari, Arsalan
Mehrabian, Fardin
Nazari, Seyed Saeed H.
Rezvani, Seyed Mahmoud
Ghasempour, Zahra
Heidarzadeh, Abtin
Mansournia, Mohammad Ali
author_sort Shakiba, Maryam
collection PubMed
description We determined the seroprevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in an affected area in northern Iran in April 2020. Antibodies to SARS-CoV-2 were detected in 528 persons by using rapid tests. Adjusted prevalence of SARS-CoV-2 seropositivity was 22.2% (95% CI 16.4%–28.5%).
format Online
Article
Text
id pubmed-7853569
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-78535692021-02-09 Seroprevalence of SARS-CoV-2 in Guilan Province, Iran, April 2020 Shakiba, Maryam Nazemipour, Maryam Salari, Arsalan Mehrabian, Fardin Nazari, Seyed Saeed H. Rezvani, Seyed Mahmoud Ghasempour, Zahra Heidarzadeh, Abtin Mansournia, Mohammad Ali Emerg Infect Dis Research Letter We determined the seroprevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in an affected area in northern Iran in April 2020. Antibodies to SARS-CoV-2 were detected in 528 persons by using rapid tests. Adjusted prevalence of SARS-CoV-2 seropositivity was 22.2% (95% CI 16.4%–28.5%). Centers for Disease Control and Prevention 2021-02 /pmc/articles/PMC7853569/ /pubmed/33349310 http://dx.doi.org/10.3201/eid2702.201960 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Research Letter
Shakiba, Maryam
Nazemipour, Maryam
Salari, Arsalan
Mehrabian, Fardin
Nazari, Seyed Saeed H.
Rezvani, Seyed Mahmoud
Ghasempour, Zahra
Heidarzadeh, Abtin
Mansournia, Mohammad Ali
Seroprevalence of SARS-CoV-2 in Guilan Province, Iran, April 2020
title Seroprevalence of SARS-CoV-2 in Guilan Province, Iran, April 2020
title_full Seroprevalence of SARS-CoV-2 in Guilan Province, Iran, April 2020
title_fullStr Seroprevalence of SARS-CoV-2 in Guilan Province, Iran, April 2020
title_full_unstemmed Seroprevalence of SARS-CoV-2 in Guilan Province, Iran, April 2020
title_short Seroprevalence of SARS-CoV-2 in Guilan Province, Iran, April 2020
title_sort seroprevalence of sars-cov-2 in guilan province, iran, april 2020
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7853569/
https://www.ncbi.nlm.nih.gov/pubmed/33349310
http://dx.doi.org/10.3201/eid2702.201960
work_keys_str_mv AT shakibamaryam seroprevalenceofsarscov2inguilanprovinceiranapril2020
AT nazemipourmaryam seroprevalenceofsarscov2inguilanprovinceiranapril2020
AT salariarsalan seroprevalenceofsarscov2inguilanprovinceiranapril2020
AT mehrabianfardin seroprevalenceofsarscov2inguilanprovinceiranapril2020
AT nazariseyedsaeedh seroprevalenceofsarscov2inguilanprovinceiranapril2020
AT rezvaniseyedmahmoud seroprevalenceofsarscov2inguilanprovinceiranapril2020
AT ghasempourzahra seroprevalenceofsarscov2inguilanprovinceiranapril2020
AT heidarzadehabtin seroprevalenceofsarscov2inguilanprovinceiranapril2020
AT mansourniamohammadali seroprevalenceofsarscov2inguilanprovinceiranapril2020

Ejemplares similares